Across the recent three months, 7 analysts have shared their insights on Oscar Health (NYSE:OSCR), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
4
2
0
0
Last 30D
0
1
0
0
0
1M Ago
0
2
1
0
0
2M Ago
1
1
1
0
0
3M Ago
0
0
0
0
0
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $24.43, along with a high estimate of $28.00 and a low estimate of $21.00. Marking an increase of 14.16%, the current average surpasses the previous average price target of $21.40.
Exploring Analyst Ratings: An In-Depth Overview
The perception of Oscar Health by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Jessica Tassan
Piper Sandler
Announces
Overweight
$25.00
-
Stephen Baxter
Wells Fargo
Raises
Overweight
$27.00
$24.00
Adam Ron
B of A Securities
Lowers
Neutral
$21.00
$25.00
Michael Ha
Baird
Announces
Outperform
$28.00
-
Adam Ron
B of A Securities
Raises
Buy
$25.00
$22.00
Stephen Baxter
Wells Fargo
Raises
Overweight
$24.00
$20.00
Nathan Rich
Goldman Sachs
Raises
Neutral
$21.00
$16.00
Key Insights:
Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' ...Full story available on Benzinga.com
Benzinga
